Debt Textual (Details)			12 Months Ended
	Apr. 17, 2023 USD ($)	Dec. 07, 2020 USD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Jul. 29, 2022 USD ($)
Debt Instrument [Line Items]
Net proceeds from secured term loans			$ 300,000,000	$ 73,072,000	$ 0
Long-term debt, total					298,142,000
Gain (loss) on extinguishment of debt			29,019,000	0	(55,838,000)
Pharmakon Advisors, LP
Debt Instrument [Line Items]
Capitalized interest rate	0.50
Pharmakon Advisors, LP | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Debt Instrument [Line Items]
Variable rate floor	0.0175
Debt instrument, basis spread on variable rate	7.00%
Pharmakon Advisors, LP | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | PIK Interest Payment is Made
Debt Instrument [Line Items]
Debt instrument, basis spread on variable rate	7.25%
Pharmakon Advisors, LP | Line of Credit
Debt Instrument [Line Items]
Periodic payment			$ 25,000,000
Debt instrument, prepayment fee, percentage of principal voluntary payments			3.00%
Pharmakon Advisors, LP | Line of Credit | Between the Second and Third Anniversaries
Debt Instrument [Line Items]
Debt instrument, prepayment fee, percentage of principal voluntary payments			3.00%
Pharmakon Advisors, LP | Line of Credit | After Third Anniversary
Debt Instrument [Line Items]
Debt instrument, prepayment fee, percentage of principal voluntary payments			2.00%
Pharmakon Advisors, LP | Line of Credit | After Fourth Anniversary
Debt Instrument [Line Items]
Debt instrument, prepayment fee, percentage of principal voluntary payments			1.00%
Athyrium | Senior Credit Facility
Debt Instrument [Line Items]
Repayments of lines of credit	$ 241,787,000
MidCap Financial Services, LLC | Senior Credit Facility
Debt Instrument [Line Items]
Repayments of lines of credit		$ 43,298,000
Loan Agreement | Pharmakon Advisors, LP
Debt Instrument [Line Items]
Debt instrument, face amount	450,000,000
Net proceeds from secured term loans	25,805,000
Term Loan Tranche A | Pharmakon Advisors, LP | Line of Credit
Debt Instrument [Line Items]
Debt instrument, face amount	$ 300,000,000
Net proceeds from secured term loans			$ 300,000,000
Effective interest rate			13.30%
Interest expense, debt, total			$ 27,326,000
Periodic payment, interest			13,663,000
Fair value disclosure			313,663,000
Debt instrument, unamortized discount (premium) and debt issuance costs, net, total			11,147,000
Amortization of debt issuance costs			715,000
Debt instrument, term (month)	18 months
Term Loan Tranche A | Pharmakon Advisors, LP | Line of Credit | PIK Interest Payment is Made
Debt Instrument [Line Items]
Percent of interest payment	0.50
Term Loan Tranche B | Pharmakon Advisors, LP | Line of Credit
Debt Instrument [Line Items]
Debt instrument, face amount	$ 50,000,000
Term Loan Tranche C | Pharmakon Advisors, LP | Line of Credit
Debt Instrument [Line Items]
Debt instrument, face amount	50,000,000
Term Loan Tranche D | Pharmakon Advisors, LP | Line of Credit
Debt Instrument [Line Items]
Debt instrument, face amount	50,000,000
Credit Agreement | Athyrium
Debt Instrument [Line Items]
Debt instrument, face amount		$ 200,000,000
Debt instrument, LIBOR floor		1.75%
Debt instrument, LIBOR cap		3.50%
Debt instrument, exit fee, percentage of principal		2.00%
Debt instrument, commitment fee percentage		1.00%
Paid-in-kind interest			8,476,000	23,387,000
Long-term debt, total	240,452,000
Interest expense, long-term debt	$ 1,335,000
Debt instrument, term (month)	17 days
Debt instrument, fee amount	$ 17,261,000
Debt issuance costs, net, total	11,758,000
Gain (loss) on extinguishment of debt	$ 29,019,000
Credit Agreement | Athyrium | London Interbank Offered Rate (LIBOR)
Debt Instrument [Line Items]
Debt instrument, basis spread on variable rate		8.25%
Credit Agreement | Athyrium | London Interbank Offered Rate (LIBOR) | PIK Interest Payment is Made
Debt Instrument [Line Items]
Debt instrument, basis spread on variable rate		10.25%
Credit Agreement | Athyrium | Term A Loan
Debt Instrument [Line Items]
Net proceeds from secured term loans		$ 125,000,000
Amortization of debt issuance costs			$ 1,069,000	$ 916,000	$ 531,000
Credit Agreement | Athyrium | Term B Loan
Debt Instrument [Line Items]
Debt instrument, face amount						$ 25,000,000
Credit Agreement | Athyrium | Term C Loan
Debt Instrument [Line Items]
Debt instrument, face amount						50,000,000
Credit Agreement | Athyrium | Term B And C Loan
Debt Instrument [Line Items]
Debt instrument, face amount						75,000,000
Deferred debt fees and issuance costs						$ 3,428,000
Credit Agreement | Athyrium | Term Loans
Debt Instrument [Line Items]
Effective interest rate			13.71%	12.87%